Form 4: AnaptysBio Director Dennis M Fenton Reports Stock Transactions
SEC Form 4 Filing
Director Dennis M Fenton of AnaptysBio, Inc. reports the vesting and disposal of 3,900 shares of common stock related to restricted stock units on June 15, 2024.
Summary
- On June 15, 2024, Dennis M Fenton, a director of AnaptysBio, Inc., reported transactions involving the company's common stock.
- Fenton acquired 3,900 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, Fenton disposed of 3,900 shares.
- The RSUs vested on the date of the Issuer's 2024 annual meeting of shareholders.
- Following these transactions, Fenton directly owns 0 shares of AnaptysBio common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of company directors.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider trading activity.
- The transactions themselves are unlikely to have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date of transaction: vesting and disposal of 3,900 shares of common stock related to restricted stock units. |
| 06/18/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.